Review Article
Intralesional Bleomycin Sclerotherapy in Children with Lymphangiomas: A Review Article
Volkan Sarper Erikci*
Sağlik Bilimleri University, Department of Pediatric Surgery, Tepecik Training Hospital, Turkey
Volkan Sarper Erikci, Associate Professor of Pediatric Surgery, Tepecik Training Hospital, Turkey.
Received Date: November 25, 2020; Published Date:December 14, 2020
Abstract
Lymphangioma is a benign tumor of lymphatic vessels. Swelling and cosmetic deformity are the most common symptoms. As a sclerosing agent, bleomycin has been used in the management of patients with these lesions with successful outcomes. In this review the topic is discussed, and a brief literature review is given. Intralesional injection of bleomycin in children with lymphangioma is an effective method of treatment and it usually achieves excellent results in most of the patients with minimal side effects.
Keywords: Lymphangioma; Bleomycin; Intralesional sclerotherapy
-
Volkan Sarper Erikci. Intralesional Bleomycin Sclerotherapy in Children with Lymphangiomas: A Review Article. Anaest & Sur Open Access J. 2(3): 2020. ASOAJ.MS.ID.000539.
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.